NCT07383974

Brief Summary

This is a randomized, double-blind, placebo-controlled clinical trial exploring the effects of a 12-week dietary supplement regimen on skin condition and perceived overall health status. The study will involve 120 healthy Chinese adults aged 18 and above with low daily fruit and vegetable intake. Participants will be randomly assigned to one of two groups: one group will take a combination of Nu Skin's Vitamin C \& Green Tea Capsules and Multivitamin \& Mineral Capsules, while the other group will take a matching placebo. The primary goal is to assess if the supplement combination improves skin health after 12 weeks, measured through specialized facial imaging (assessing spots, redness, evenness) and probe measurements (assessing elasticity, moisture, gloss). Secondary goals include evaluating changes in participants' self-perceived health status (via quality of life, fatigue, and digestive health questionnaires), psychological resilience, memory, and exploring a new method for measuring skin carotenoid levels. This study is not intended to verify the approved health functions of the products but to explore the potential combined effects of antioxidant and nutritional supplementation on skin and general well-being.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P75+ for not_applicable healthy-volunteers

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable healthy-volunteers

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 3, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 19, 2026

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 2, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 3, 2026

Completed
Last Updated

February 3, 2026

Status Verified

January 1, 2026

Enrollment Period

3 months

First QC Date

January 19, 2026

Last Update Submit

January 26, 2026

Conditions

Outcome Measures

Primary Outcomes (7)

  • Facial Image Capture VISIA-7

    Imaging sessions are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks)

  • Skin Elasticity Test Probe Cutometer

    Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks)

  • Skin Gloss Measurement Glossmeter

    Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).

  • Skin Moisture Content Corneometer

    Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks)

  • Skin Hemoglobin Measurement Mexameter MX18 (Courage & Khazaka, Germany)

    Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).

  • Skin Moisture Loss Meter Vapometer (Delfin, Finland)

    Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).

  • Skin Carotenoid Index

    Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).

Secondary Outcomes (5)

  • Skin Condition Survey

    The scales and questionnaires are administered at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).

  • Physical Health and Life Status Survey

    The survey is administered at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).

  • Psychological State and Memory Level

    The assessment is conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).

  • Self-Evaluation Questionnaire

    This questionnaire is administered only at follow-up visits: T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).

  • Height and Weight Measurement BMI

    Measurements are conducted at T0 (baseline, upon enrollment) and T12w (12 weeks).

Study Arms (2)

Supplement Combination Group

EXPERIMENTAL
Dietary Supplement: Vitamin C & Green Tea Capsules + Multivitamin & Mineral Capsules Combination

Placebo Control Group

PLACEBO COMPARATOR
Dietary Supplement: Placebo Combination (Matching)

Interventions

Participants take a matching placebo combination (identical in appearance and taste to the active supplements) orally twice daily

Placebo Control Group

Participants take a combination of active supplements-specifically, Vitamin C \& Green Tea Capsules and Multivitamin \& Mineral Capsules-orally twice daily.

Supplement Combination Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chinese adults of Asian descent aged 18 and above;
  • Daily fruit and vegetable intake \< 240g (calculated based on the fruit and vegetable section of the food frequency questionnaire);
  • S3 measurement index \< 30000;
  • Participants must possess basic Chinese reading comprehension and expression skills, and be able to independently complete questionnaire surveys;
  • Voluntary participation in the test and signing of the informed consent form;
  • Willingness to comply with all evaluation requirements.

You may not qualify if:

  • Presence of open facial skin lesions, clearly visible scars, acne marks, etc.;
  • Skin lesions, scars, or significant pigmentation on the hand measurement area;
  • Symptoms of skin disease on the face or hand measurement areas;
  • Having undergone medical aesthetic procedures within the last 6 months;
  • Participation in other clinical trials involving product use within the last 3 months;
  • Use of health supplements or nutritional supplements (e.g., vitamins, minerals) within the last 1 month;
  • Currently planning for pregnancy, pregnant, or lactating;
  • Presence of any disease under current treatment;
  • Any other health issues or chronic diseases that affect behavioral or cognitive abilities;
  • Other iatrogenic reasons identified by experts or professionals that may affect the evaluation results.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai China-norm Quality Technical Service Co., Ltd.

Shanghai, Shanghai Municipality, 200072, China

RECRUITING

MeSH Terms

Interventions

Ascorbic AcidTeaGeritolMinerals

Intervention Hierarchy (Ancestors)

Sugar AcidsAcids, AcyclicCarboxylic AcidsOrganic ChemicalsHydroxy AcidsCarbohydratesPlant PreparationsBiological ProductsComplex MixturesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesInorganic Chemicals

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2026

First Posted

February 3, 2026

Study Start

November 3, 2025

Primary Completion

February 2, 2026

Study Completion

February 2, 2026

Last Updated

February 3, 2026

Record last verified: 2026-01

Locations